By starting with or maintaining lower doses, providers hope to balance effectiveness with tolerability
Most patients find that injection-site tolerance improves significantly after the first few doses as proper technique becomes routine
When administering the lower dose of Semaglutide at 1 mg to treat patients with diabetes, the SUSTAIN study consistently demonstrated significant improvements in glucose control and body weight reduction 29,30,31,32,33,34,35
In summary, there is a considerable number of clinical studies reporting the potential benefit of GLP-1RAs for use in cognitive disorders, including dementias and Parkinsons disease, although the majority are observational and can only suggest association
Your dose might absorb fully one week and partially the next, leading to inconsistent appetite suppression and unpredictable appetite control